Events

In this webinar, Peter Warn will review the experimental design and conduct of advanced or complex animal models for antimicrobial research. This webinar is designed as a follow on from the webinar of William J. Weiss: Models for antimicrobial R&D: Development and use of in vivo models for infectious disease research (see here: http://bit.ly/2ZiPt6y). Topics […]

Join HHS Secretary, Alex Azar, experts from the U.S. Centers for Disease Control and Prevention, and hundreds of organizational and global leaders for an evening celebrating the culmination of the AMR Challenge at an unofficial side event of the 74th United Nations General Assembly in New York City.

Attendees include Richard Alm, CARB-X Alliance Director. IDWeek is the joint annual meeting of the Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), the HIV Medical Association (HIVMA), and the Pediatric Infectious Diseases Society (PIDS). At IDWeek, you will see familiar colleagues and new faces. IDWeek is a forum for […]

In this webinar, Olga Genilloud will discuss the role of natural products in current antibiotic discovery. Topics discussed will include: Screening strategies to identify novel antibiotics Current challenges and novel analytical tools New omic approaches supporting antibiotic discovery The presentation will be followed by a Q&A session.   Speaker: Olga Genilloud, Scientific Director, Fundación MEDINA, […]

Despite drug resistance growing, the development of new antibiotics has slowed. How can policymakers help accelerate the pace of new drug development, and how can all of us—doctors, hospitals, and patients, as well as the agricultural sector—be better stewards of existing drugs? Forum panelists will examine the scope of this looming crisis and look at how changes in policy and practice can help us stay one step ahead of these superbugs.

Speakers include Erin Duffy, CARB-X Chief of Research and Development. The emergence and spread of bacteria resistant to many drug classes seriously threaten all branches of modern medicine. There is currently no course providing advanced instruction on antibiotics and resistance. The specific goal of ICARe is to bring leaders in academics and industry together with […]

Kevin Outterson, Executive Director of CARB-X, will be speaking at the Harvard Chan School of Public Health. This presentation is sponsored by Harvard Antimicrobial Resistance (HAMR) a subgroup of the Harvard Infectious Diseases Consortium. For more information, visit harvardamr.com   

Kevin Outterson, Executive Director of CARB-X, will be giving the keynote Address on November 7th, titled "A vision for a health antibiotic R&D ecosystem".  Outterson will also be participating on a panel titled "Analyzing the potential impact of current commercial and “pull” initiatives" on November 7th. Karen Gallant, Deputy Executive Director of CARB-X, will be […]

This webinar by Paul Hergenrother (Department of Chemistry and the Institute for Genomic Biology University of Illinois, US) will detail his research group's efforts to understand compound accumulation in the Gram-negative ESKAPE pathogens. Emphasis will be placed on the practicality, actionability, and translatability of this information, specifically, the use of accumulation rules to convert high-value […]

Presenters include Karen Gallant, Deputy Executive Director of CARB-X. Few technologies have the potential to disrupt and eliminate infectious disease and viral infections– but gene editing, CRISPR in particular, is a latent technology that could change biotech – and we’re just seeing the beginning of what effect it could have on the world. With scientific […]